<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-Z4UHFWN3/cc6b843c-4c83-4742-8de9-8ed0998a7f56/HTML"><dcterms:extent>14 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-Z4UHFWN3/5d9d46f9-7f69-4180-94f2-246021ab15f3/PDF"><dcterms:extent>515 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-Z4UHFWN3/ee271bd8-523c-4899-a9cc-b3bc93aaa0e7/TEXT"><dcterms:extent>12 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1929-2026"><edm:begin xml:lang="en">1929</edm:begin><edm:end xml:lang="en">2026</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-Z4UHFWN3"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp" /><dcterms:issued>2010</dcterms:issued><dc:creator>Skitek, Petra</dc:creator><dc:creator>Stirn-Kranjc, Branka</dc:creator><dc:format xml:lang="sl">4 strani</dc:format><dc:format xml:lang="sl">letnik:79</dc:format><dc:format xml:lang="sl">str. I-177-I-180</dc:format><dc:format xml:lang="sl">številka:suplement</dc:format><dc:identifier>ISSN:1318-0347</dc:identifier><dc:identifier>COBISSID:3788607</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-Z4UHFWN3</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko zdravniško društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Zdravniški vestnik</dcterms:isPartOf><dc:subject xml:lang="sl">Astrocitom</dc:subject><dc:subject xml:lang="en">Astrocytoma</dc:subject><dc:subject xml:lang="en">Chemotherapy, Adjuvant</dc:subject><dc:subject xml:lang="en">Child</dc:subject><dc:subject xml:lang="sl">gliom</dc:subject><dc:subject xml:lang="sl">Kemoterapija, pomožna</dc:subject><dc:subject xml:lang="sl">novotvorbe</dc:subject><dc:subject xml:lang="sl">oftalmologija</dc:subject><dc:subject xml:lang="en">Optic Nerve Glioma</dc:subject><dc:subject xml:lang="sl">otroci</dc:subject><dc:subject xml:lang="sl">Otrok</dc:subject><dc:subject xml:lang="en">therapy</dc:subject><dc:subject xml:lang="en">tumor</dc:subject><dc:subject xml:lang="sl">vidni živec</dc:subject><dc:subject xml:lang="sl">Vidni živec, gliom</dc:subject><dc:subject xml:lang="sl">zdravljenje</dc:subject><dcterms:temporal rdf:resource="1929-2026" /><dc:title xml:lang="sl">Razširjeni gliom vidne poti pri najstniku| Extensive optic pathway glioma in a teenager|</dc:title><dc:description xml:lang="sl">Background: Optic pathway gliomas are rare, but the most common primary tumours of the optic nerve. They affect children more than adults. Management of these patients requires an individualized and multidisciplinary approach. Case report: A clinical course and ophthalmological, electrophysiological, neuroradiological, neurosurgical and paediatric-oncological management of an extensive optic pathway glioma in a teenager with unspecific visual problems are presented. Conclusions: Although most frequently low grade astrocytomas, optic pathway gliomas follow a highly variable and unpredictable clinical course. Therefore, their optimal management is still controversial. In the last decade, chemotherapy has become the first-line treatment modality, especially in inoperable and/or extended gliomas</dc:description><dc:description xml:lang="sl">Izhodišča: Gliomi vidne poti so redki, vendar najpogostejši primarni tumorji vidnega živca, ki prizadenejo otroke pogosteje kot odrasle. Njihova obravnava zahteva individualizirani in multidisciplinarni pristop. Prikaz primera: V prispevku je predstavljen klinični potek in oftalmološka, elektrofiziološka, nevroradiološka, nevrokirurška ter onkološko pediatrična obravnava razširjenega glioma vidne poti pri najstniku z nespecifičnimi motnjami vida. Zaključki: Čeprav so gliomi vidne poti najpogosteje nizko maligni astrocotomi, je njihov klinični potek zelo različen in nepredvidljiv, zaradi česar njihovo optimalno zdravljenje še vedno ni povsem dorečeno. V zadnjem desetletju je postalo zdravljenje prve izbire kemoterapija, še posebej pri neoperabilnih in/ali razširjenih gliomih</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-Z4UHFWN3"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-Z4UHFWN3" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-Z4UHFWN3/5d9d46f9-7f69-4180-94f2-246021ab15f3/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko zdravniško društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-Z4UHFWN3/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-Z4UHFWN3" /></ore:Aggregation></rdf:RDF>